Clinical Trial Update: Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke [NA]

View source ↗

Summary

A clinical trial update describing the plan to discontinue antithrombotic therapy after patent foramen ovale closure in young patients with cryptogenic ischemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptogenic Stroke
• Patent Foramen Ovale
• Stroke

Snippet

Sponsor: Josep Rodes-Cabau | Conditions: Patent Foramen Ovale, Ischemic Stroke | NA | Status: RECRUITING